The store will not work correctly when cookies are disabled.
N-(2-Carbamoylphenyl)quinoline-2-carboxamide
ID: ALA4743267
PubChem CID: 10565494
Max Phase: Preclinical
Molecular Formula: C17H13N3O2
Molecular Weight: 291.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1ccccc1NC(=O)c1ccc2ccccc2n1
Standard InChI: InChI=1S/C17H13N3O2/c18-16(21)12-6-2-4-8-14(12)20-17(22)15-10-9-11-5-1-3-7-13(11)19-15/h1-10H,(H2,18,21)(H,20,22)
Standard InChI Key: VYYZIAKXTBFCAB-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
7.2998 -6.1476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1246 -6.1428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5414 -6.8548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5330 -5.4259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3579 -5.4211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7725 -6.1350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5966 -6.1304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0058 -5.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5846 -4.6988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7619 -4.7067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3423 -3.9957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7480 -3.2775 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5173 -4.0035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8860 -5.4351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0618 -5.4396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8967 -6.8634 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0738 -6.8713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6544 -6.1570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8279 -6.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4198 -6.8849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8444 -7.5999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6695 -7.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 1 0
11 13 2 0
10 11 1 0
1 14 2 0
14 15 1 0
15 18 2 0
17 16 2 0
16 1 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.31 | Molecular Weight (Monoisotopic): 291.1008 | AlogP: 2.59 | #Rotatable Bonds: 3 |
Polar Surface Area: 85.08 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.92 | CX Basic pKa: ┄ | CX LogP: 3.11 | CX LogD: 3.11 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -1.41 |
References
1. Nijampatnam B,Ahirwar P,Pukkanasut P,Womack H,Casals L,Zhang H,Cai X,Michalek SM,Wu H,Velu SE. (2021) Discovery of Potent Inhibitors of Streptococcus mutans Biofilm with Antivirulence Activity., 12 (1): [PMID:33488963] [10.1021/acsmedchemlett.0c00373] |